New drug combo aims to stop kidney cancer from coming back
Disease control
Recruiting now
This study is testing whether giving two cancer drugs (axitinib and a PD-1 antibody) before surgery can help stop kidney cancer from returning. It will involve 298 patients with high-risk kidney cancer who are scheduled for surgery. Patients will be randomly assigned to receive e…
Phase: PHASE3 • Sponsor: ZHOU FANGJIAN • Aim: Disease control
Last updated Mar 31, 2026 12:13 UTC